Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leda R Castilho

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
The Journal of Experimental Medicine|July 22, 2021
The immunodominant antibody response to Zika virus NS1 protein is characterized by cross-reactivity to selfCecilia B Cavazzoni, Vicente B T Bozza, Tostes C V Lucas, et al.
The American Journal of Tropical Medicine and Hygiene|February 10, 2026
Potent Monoclonal Antibodies Against Circulating Yellow Fever Virus Strains from Donors Immunized with the 17D VaccineMatheus O de Souza, Danielle R D Saunders, Andrew Miller, et al.
Frontiers in Immunology|June 27, 2022
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 StudyRafaella F Q Grenfell, Nathalie B F Almeida, Priscilla S Filgueiras, et al.
Science (New York, N.Y.)|October 7, 2016
Rapid development of a DNA vaccine for Zika virusKimberly A Dowd, Sung-Youl Ko, Kaitlyn M Morabito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 25, 2025
Highly efficient and low-cost single-cell culture platform for unbiased analysis of human memory B cell repertoire and antibody discoveryLuciana Conde, Debora L Oliveira, Gabriela Maciel, et al.
Vaccines|November 25, 2023
Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 InfectionMomtchilo Russo, Maria Cássia Mendes-Corrêa, Bruna B Lins, et al.
Iscience|November 1, 2021
Polyclonal F(ab')<sub>2</sub> fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potencyLuis Eduardo R Cunha, Adilson A Stolet, Marcelo A Strauch, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
The Journal of Experimental Medicine|July 22, 2021
The immunodominant antibody response to Zika virus NS1 protein is characterized by cross-reactivity to selfCecilia B Cavazzoni, Vicente B T Bozza, Tostes C V Lucas, et al.
The American Journal of Tropical Medicine and Hygiene|February 10, 2026
Potent Monoclonal Antibodies Against Circulating Yellow Fever Virus Strains from Donors Immunized with the 17D VaccineMatheus O de Souza, Danielle R D Saunders, Andrew Miller, et al.
Frontiers in Immunology|June 27, 2022
Immunogenicity, Effectiveness, and Safety of Inactivated Virus (CoronaVac) Vaccine in a Two-Dose Primary Protocol and BNT162b2 Heterologous Booster in Brazil (Immunita-001): A One Year Period Follow Up Phase 4 StudyRafaella F Q Grenfell, Nathalie B F Almeida, Priscilla S Filgueiras, et al.
Science (New York, N.Y.)|October 7, 2016
Rapid development of a DNA vaccine for Zika virusKimberly A Dowd, Sung-Youl Ko, Kaitlyn M Morabito, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 25, 2025
Highly efficient and low-cost single-cell culture platform for unbiased analysis of human memory B cell repertoire and antibody discoveryLuciana Conde, Debora L Oliveira, Gabriela Maciel, et al.
Vaccines|November 25, 2023
Intranasal Liposomal Formulation of Spike Protein Adjuvanted with CpG Protects and Boosts Heterologous Immunity of hACE2 Transgenic Mice to SARS-CoV-2 InfectionMomtchilo Russo, Maria Cássia Mendes-Corrêa, Bruna B Lins, et al.
Iscience|November 1, 2021
Polyclonal F(ab')<sub>2</sub> fragments of equine antibodies raised against the spike protein neutralize SARS-CoV-2 variants with high potencyLuis Eduardo R Cunha, Adilson A Stolet, Marcelo A Strauch, et al.
Pageof 5